Hualan Biological Vaccine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	352.94	623.04	640.98	600.04	131.56
Short-Term Investments	-	1,145	373.46	130	-
Trading Asset Securities	1,973	1,458	1,599	1,419	825.82
Cash & Short-Term Investments	2,326	3,227	2,613	2,149	957.39
Cash Growth	-27.91%	23.48%	21.57%	124.50%	10.65%
Accounts Receivable	1,349	1,438	1,990	1,796	1,439
Other Receivables	0.01	0.41	1.31	0.41	2.15
Receivables	1,349	1,438	2,412	1,856	1,441
Inventory	179.2	208.84	173.47	167.16	107.41
Other Current Assets	528.45	103.13	28.18	20.22	23.31
Total Current Assets	4,383	4,977	5,227	4,193	2,529
Property, Plant & Equipment	943.71	1,071	1,176	1,287	1,351
Long-Term Investments	-	1,204	1,296	1,310	356.3
Other Intangible Assets	20.09	20.88	20.13	20.78	21.43
Long-Term Deferred Tax Assets	189.06	212.73	217.97	208.56	182.9
Long-Term Deferred Charges	27.92	27.79	27.94	28.69	33.36
Other Long-Term Assets	1,280	11.05	30.61	27.98	48.93
Total Assets	6,844	7,523	7,995	7,076	4,523
Accounts Payable	60.98	81.78	116.76	125.67	185.5
Accrued Expenses	-	903.53	1,155	1,050	929.48
Short-Term Debt	-	300.18	300.18	300.18	500.44
Current Portion of Leases	-	-	-	-	1.03
Current Income Taxes Payable	3.96	-	50.81	9.24	15.99
Current Unearned Revenue	3.6	8.74	2.67	2.68	1.54
Other Current Liabilities	1,048	169.9	60.63	49.13	38.19
Total Current Liabilities	1,117	1,464	1,686	1,537	1,672
Long-Term Leases	-	-	-	-	0.81
Long-Term Unearned Revenue	22.95	27.19	31.42	35.66	39.89
Long-Term Deferred Tax Liabilities	-	18.8	15.22	6.41	2.5
Total Liabilities	1,140	1,510	1,732	1,579	1,715
Common Stock	601.03	601.03	600.02	400.01	360
Additional Paid-In Capital	2,910	2,926	2,915	3,089	879.79
Retained Earnings	2,300	2,593	2,748	2,008	1,568
Treasury Stock	-106.79	-106.79	-	-	-
Shareholders' Equity	5,704	6,013	6,263	5,497	2,808
Total Liabilities & Equity	6,844	7,523	7,995	7,076	4,523
Total Debt	-	300.18	300.18	300.18	502.27
Net Cash (Debt)	2,326	2,926	2,313	1,849	455.12
Net Cash Growth	-20.51%	26.53%	25.07%	306.31%	-31.59%
Net Cash Per Share	3.91	4.89	3.84	3.13	0.84
Filing Date Shares Outstanding	595.48	595	600.02	600.02	600.02
Total Common Shares Outstanding	595.48	595	600.02	600.02	540
Working Capital	3,266	3,512	3,541	2,656	857.07
Book Value Per Share	9.58	10.11	10.44	9.16	5.20
Tangible Book Value	5,684	5,992	6,243	5,476	2,787
Tangible Book Value Per Share	9.55	10.07	10.40	9.13	5.16
Buildings	-	376.55	376.55	376.19	375.5
Machinery	-	1,496	1,472	1,450	1,388
Construction In Progress	-	6.72	3.23	3.26	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.